Background Alopecia areata (AA) is a complex autoimmune condition resulting in
nonscarring hair loss. In recent years, many studies have provided new evidence on …

Alopecia areata (AA) presents a challenging and unpredictable condition associated with
substantial psychosocial and financial burdens. A chronic, relapsing form of non-scarring …

Introduction Alopecia areata (AA) can negatively affect quality of life (QoL) and is associated
with increased prevalence of anxiety and depression (vs people without AA). This study …

Alopecia area (AA) is a common autoimmune disorder, characterized by hair loss. Although
its impact on quality of life is fairly well understood, studies on the economic impact of AA are …

Introduction: Alopecia areata (AA) is an immune-mediated hair loss condition with
substantial psychosocial impact. The impact of AA on social interactions at work has not …

Background Tralokinumab, a humanized monoclonal antibody targeting interleukin-13, has
been primarily used for the treatment of moderate-to-severe atopic dermatitis. Given its …

Objectives This study aims to update the understanding of Alopecia Areata (AA) in Poland,
Czechia, Russia, and Türkiye, focusing on the disease burden, clinical management, and …

Visible physical differences may have a variety of social and psychological effects. Complete
hair loss on the scalp and body is a defining feature of the deforming disorder alopecia …

Introduction Alopecia areata (AA) is an autoimmune disease associated with high rates of
emotional and psychosocial distress. The analysis reported here describes the evolution of …

Objective The objective of this study is to elucidate the causal association between asthma
and alopecia areata (AA) through the application of Mendelian randomization (MR) analysis …